Serologic response to lower-molecular-weight proteins of H. pylori is related to clinical outcome of H. pylori infection in Taiwan

Digestive Diseases and Sciences

Volumn 45, Issue 4, 2000, Pages 781-788

  Shiesh, Shu Chu ^a   Sheu, Bor Shyang ^a,b   Yang, Hsiao Bai ^a   Tsao, Hui Jane ^a   Lin, Xi Zhang ^a  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^b NATIONAL CHENG KUNG UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Bacterial density; Duodenal ulcer; Gastric malignancy; H. pylori; Serological response; Western blotting

Indexed keywords

ANTIBODY DETECTION; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DYSPEPSIA; ENDOSCOPY; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HUMAN; MAJOR CLINICAL STUDY; PEPTIC ULCER; PRIORITY JOURNAL; PROTEIN ANALYSIS; SEROLOGY; STOMACH BIOPSY; STOMACH CANCER; STOMACH DISEASE; TAIWAN;

ANTIBODIES, BACTERIAL; BACTERIAL PROTEINS; BLOTTING, WESTERN; CASE-CONTROL STUDIES; DYSPEPSIA; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; IMMUNOGLOBULIN G; LYMPHOMA, MUCOSA-ASSOCIATED LYMPHOID TISSUE; MALE; MIDDLE AGED; MOLECULAR WEIGHT; PEPTIC ULCER; STOMACH NEOPLASMS; TAIWAN;

EID: 0034112266     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1005460130305     Document Type: Article

References (34)

1. 1. Warren JR, Marshall BJ: Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet 1:1273-1275, 1983
2. 2. Graham DY: Campylobacter pylori and peptic ulcer disease. Gastroenterology 96:615-625, 1989
3. 3. Blaser MJ, Perez-Perez GI, Kleanthous H, Cover TL, Peek RM, Chyou PH, Stemmermann GN, Nomura A: Infection with Helicobacter pylori strains possessing CagA is associated with an increased risk of developing adenocarcinoma of the stomach. Cancer Res 55:2111-2115, 1995
4. 4. Cover TL, Blaser MJ: Helicobacter pylori infection, a paradigm for chronic mucosal inglammation: Pathogenesis and implications for eradication and prevention. Adv Intern Med 41:85-117, 1996
5. 5. Marshall BJ: Helicobacter pylori: The etiologic agent for peptic ulcer. JAMA 274:1064-1066, 1995
6. 6. Go MF: What are the host factors that place an individual at risk for Helicobacter pylori-associated disease? Gastroenterology 113:S15-S20, 1997
7. 7. Mobley HLT: Helicobacter pylori factors associated with disease development. Gastroenterology 113:521-528, 1997
8. 8. Crabtree JE, Farmery SM, Lindley IKD, Figura N, Peichl P, Tompkins DS: CagA/cytotoxic strains of Helicobacter pylori and interleukin-8 in gastric epithelial cell lines. J Clin Pathol 47:945-950, 1994
9. 9. Cover TL, Dooley CP, Blaser MJ: Characterization of and human serologic response to proteins in Helicobacter pylori broth culture supernatants with vacuolizing cytotoxin activity. Infect Immun 58:603-610, 1990
10. 10. Crabtree JE, Suerbaum S, Andersen LP, Angelico M, Figura N, Moran AP, Olbe L, Wadstrom T, McColl K, Logan R: Uptake on Helicobacter pylori research: Pathogenesis and host response. Eur J Gastroenterol Hepatol 9:619-620, 1997
11. 11. Cover TL, Glupezynski Y, Lage AP, Burette A, Tummuru MK, Perez-Perez GI, Blaser MJ: Serologic detection of infection with CagA Helicobacter pylori strains. J Clin Microbiol 33:1496-1500, 1995
12. 12. Blaser MJ, Crabtree JE: CagA and the outcome of Helicobacter pylori infection. Am J Clin Pathol 106:565-567, 1996
13. 13. Crabtree JE: Role of cytokines in pathogenesis of Helicobacter pylori-induced mucosal damage. Dig Dis Sci 43(suppl 9):46S-55S, 1998
14. 14. Xiang Z, Censini S, Bayeli PF, Telford JL, Figura N, Rappuoli R: Analysis of expression of CagA and VacA virulence factors in 43 strains of Helicobacter pylori reveals that clinical isolates can be divided into two major types and that CagA is not necessary for expression of the vacuolating cytotoxin. Infect Immun 63:94-98, 1995
15. 15. Marchetti M, Arico B, Burroni D, Figura N, Rappuoli R, Ghiara P: Development of a mouse model of Helicobacter pylori infection that mimics human disease. Science 267:1655-1658, 1995
16. 16. Owen RJ, Hurtado A, Banatvala N, Abdi Y, Davies GR, Feldman R, Hardie JM: Conservation of the cytotoxin-association with vacuolating-cytotoxin activity and gastroduodenal disease. FEMS Immunol Med Microbiol 9:307-315, 1994
17. 17. Mitchell HM, Hazell SL, Li YY, Hu PJ: Serological response to specific Helicobacter pylori antigens: Antibody against CagA antigen is not predictive of gastric cancer in a developing country. Am J Gastroenterol 91:1785-1788, 1996
18. 18. Maeda S, Kanai F, Ogura K, Yoshida H, Ikenoue T, Takahashi M, Kawabe T, Shiratori Y, Omata M: High seropositivity of anti-CagA antibody in Helicobacter pylori-infected patients irrelevant to peptic ulcers and normal mucosa in Japan. Dig Dis Sci 42:1841-1847, 1997
19. 19. Yang JC, Wang TH, Wang HJ, Kuo CH, Wang JT, Wang WC: Genetic analysis of the cytotoxin-associated gene and the vacuolating toxin gene in Helicobacter pylori strains isolated from Taiwanese patients. Am J Gastroenterol 92:1316-1321, 1997
20. 20. Ricci V, Ciacci C, Zarrilli R, Sommi P, Tummuru MK, Del Vecchio, Blanco C, Bruni CB, Cover TL, Blaser MJ, Romano M: Effect of Helicobacter pylori on gastric epithelial cell migration and proliferation in vitro: Role of VacA and CagA. Infect Immun 64:2829-2833, 1996
21. 21. Davies GR, Banatvala N, Collins CE, Sheaff MT, Abdi Y, Clements L, Rampton DS: Relationship between infective load of Helicobacter pylori and reactive oxygen metabolite production in antral mucosa. Scand J Gastroenterol 29:419-424, 1994
22. 22. Yang HB, Sheu BS, Su IJ, Chien CH, Lin XZ: Clinical application of gastric histology to monitor treatment of dual therapy in H. pylori eradication. Dig Dis Sci 42:1835-1840, 1997
23. 23. Sheu BS, Yang HB, Su IJ, Sheish SH, Chi CH, Lin XZ: Bacterial density of H. pylori is predictive of the treatment success of triple therapy in bleeding duodenal ulcers. Gastrointest Endosc 43:683-688, 1996
24. 24. Laine L, Chun D, Stein C, El-Beblawi I, Sharma V, Chandrasoma P: The influence of size or number of biopsies on rapid urease test results: A prospective evaluation. Gastrointest Endosc 43:49-53, 1996
25. 25. Wu MS, Shun CT, Lee SC, Chen CJ, Wang HP, Lee WJ, Sheu JC, Lin JT: Gastric cancer risk in relation to Helicobacter pylori infection and subtypes of intestinal metaplasia. Br J Cancer 78:125-128, 1998
26. 26. Sheu BS, Wu JJ, Yang HB, Huang AH, Lin XZ: One-week proton pump inhibitor-based triple therapy is effective to eradicate the residual H. pylori after dual therapy. J Formos Med Assoc 97:266-270, 1998
27. 27. Vaira D, Holton J, Menegatti M, Landi F, Ricci C, Ali A, Gatta L, Farinelli S, Acciardi C, Massardi B, Miglioli M: Blood tests in the management of Helicobacter pylori infection. Gut 43(suppl):39S-46S, 1998
28. 28. Kosunen TU, Seppala K, Sarna S, Sipponen P: Diagnostic value of decreasing IgG, IgA and IgM antibody tilers after eradication of Helicobacter pylori. Lancet 339:893-895, 1992
29. 29. Tham TC, McLaughlin N, Hughes DF, Ferguson M, Crosbie JJ, Madden M, Namnyak S, O'Connor FA: Possible role of Helicobacter pylori serology in reducing endoscopy workload. Postgrad Med J 70:809-812, 1994
30. 30. Evans DJ Jr, Evans DG, Graham DY, Klein, PD: A sensitive and specific serologic test for detection of Campylobacter pylori infection. Gastroenterology 96:1004-1008, 1989
31. 31. Tummuru MKR, Cover TL, Blaser MJ: Cloning and expression of a high-molecular-mass major antigen of Helicobacter pylori: Evidence of linkage to cytotoxin production. Infect Immun 61:1799-1809, 1993
32. 32. Ching CK, Wong BCY, Kwok E, Ong L, Covacci A, Lam SK: Prevalence of CagA-hearing Helicobacter pylori strains detected by the anti-CagA assay in patients with peptic ulcer disease and in controls. Am J Gastroenterol 91:949-953, 1996
33. 33. Aucher P, Petit ML, Mannant PR, Pezennec L, Babin P, Fauchere JL. Use of immunoblot assay to define serum antibody patterns associated with Helicobacter pylori infection and with H. pylori-related ulcers. J Clin Microbiol 36:931-936, 1998
34. 34. Wang JT, Chang CS, Lee CZ, Yang JC, Lin JT, Wang TH: Antibody to a Helicobacter pylori species specific antigen in patients with adenocarcinoma of the stomach. Biochem Biochim Res Commun 244:360-363, 1998